Metformin therapy and severity and mortality of SARS-CoV-2 infection: a meta-analysis

Volume: 10, Issue: 4, Pages: 317 - 329
Published: Sep 9, 2021
Abstract
Background: It has been postulated that metformin could have anti-SARS-CoV-2 action. This raises the hypothesis that people who take metformin may have lower SARS-CoV-2 severity and/or mortality. Objective To conduct a meta-analysis of the association between the use of Metformin and risk of severity and mortality in SARS-CoV-2 infection. Data Sources We searched PubMed, EMBASE, Google scholar, the Cochrane Database of Systematic...
Paper Details
Title
Metformin therapy and severity and mortality of SARS-CoV-2 infection: a meta-analysis
Published Date
Sep 9, 2021
Volume
10
Issue
4
Pages
317 - 329
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.